SEC 01design + devREV 2023
Calidi Biotherapeutics
SEC 02Overview
Website for a clinical-stage biotech company developing targeted immunotherapies for cancer. Needed to balance scientific credibility with accessibility for investors.
SEC 03The Work
Designed and built the full site. Clean, authoritative visual language with generous whitespace and clear information hierarchy. Pipeline pages, investor content, team bios — all responsive and fast.
SEC 04Tech
[ Webflow ][ Custom Design ][ UI/UX ][ CMS ]